Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer.
Wang B, Wang SW, Zhou Y, Wang SP, Gao Y, Liu HM, Ji SK, Wang SQ, Zheng YC, Zhang C, Mardinoglu A, Liu HM, Chen XB, Dai XJ.
Wang B, et al. Among authors: wang sq.
J Med Chem. 2024 Sep 12. doi: 10.1021/acs.jmedchem.4c00972. Online ahead of print.
J Med Chem. 2024.
PMID: 39264726